Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Bast

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Netherlands Journal of Medicine|October 1, 1991
Monoclonal gammopathy as a model for B-cell differentiation: from "paraprotein" to artificial antibodiesE J Bast, B van Camp
Journal of Autoimmunity|February 1, 1995
Associated autoimmunity in Addison's diseaseP M Zelissen, E J Bast, R J Croughs
Nederlands Tijdschrift Voor Geneeskunde|September 20, 1986
[Difficulties in the diagnosis and therapy of patients with tumors of the lymphatic system]G C de Gast, E J Bast, H J Schuurman
Nederlands Tijdschrift Voor Geneeskunde|September 20, 1986
[Malignant disorders of the lymphatic system]E J Bast, G C de Gast, H J Schuurman
The Journal of Clinical Investigation|December 1, 1983
Selective deficiency of immunoglobulin A2E van Loghem, B J Zegers, E J Bast, et al.
Clinical and Experimental Immunology|January 1, 1986
T cells in B cell chronic lymphocytic leukaemia. I. Decreased frequency of T lymphocytes secreting suppressor factorA C Bloem, J C Clevers, E J Bast, et al.
British Journal of Haematology|January 1, 1989
VAD chemotherapy for refractory multiple myelomaH M Lokhorst, O J Meuwissen, E J Bast, et al.
The American Journal of Medicine|April 1, 1990
J chain disease: an aggressive evolution of multiple myelomaH M Lokhorst, A W Dekker, J V Baarlen, et al.
Clinical and Experimental Immunology|March 1, 1982
Idiotypic peripheral blood lymphocytes in monoclonal gammopathyE J Bast, B van Camp, P Reynaert, et al.
Blood|April 15, 1995
Evaluation of CD38 as target for immunotherapy in multiple myelomaW C Vooijs, H J Schuurman, E J Bast, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Netherlands Journal of Medicine|October 1, 1991
Monoclonal gammopathy as a model for B-cell differentiation: from "paraprotein" to artificial antibodiesE J Bast, B van Camp
Journal of Autoimmunity|February 1, 1995
Associated autoimmunity in Addison's diseaseP M Zelissen, E J Bast, R J Croughs
Nederlands Tijdschrift Voor Geneeskunde|September 20, 1986
[Difficulties in the diagnosis and therapy of patients with tumors of the lymphatic system]G C de Gast, E J Bast, H J Schuurman
Nederlands Tijdschrift Voor Geneeskunde|September 20, 1986
[Malignant disorders of the lymphatic system]E J Bast, G C de Gast, H J Schuurman
The Journal of Clinical Investigation|December 1, 1983
Selective deficiency of immunoglobulin A2E van Loghem, B J Zegers, E J Bast, et al.
Clinical and Experimental Immunology|January 1, 1986
T cells in B cell chronic lymphocytic leukaemia. I. Decreased frequency of T lymphocytes secreting suppressor factorA C Bloem, J C Clevers, E J Bast, et al.
British Journal of Haematology|January 1, 1989
VAD chemotherapy for refractory multiple myelomaH M Lokhorst, O J Meuwissen, E J Bast, et al.
The American Journal of Medicine|April 1, 1990
J chain disease: an aggressive evolution of multiple myelomaH M Lokhorst, A W Dekker, J V Baarlen, et al.
Clinical and Experimental Immunology|March 1, 1982
Idiotypic peripheral blood lymphocytes in monoclonal gammopathyE J Bast, B van Camp, P Reynaert, et al.
Blood|April 15, 1995
Evaluation of CD38 as target for immunotherapy in multiple myelomaW C Vooijs, H J Schuurman, E J Bast, et al.
Pageof 3